Does aspirin cause alopecia in women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Aspirin Cause Alopecia in Women?

No, aspirin does not directly cause alopecia in women based on current FDA labeling and available evidence, though it may indirectly reduce the effectiveness of minoxidil treatment for hair loss.

Direct Evidence from FDA Labeling

The FDA-approved aspirin labeling does not list alopecia or hair loss as a recognized adverse effect 1. The official warnings focus on Reye's syndrome in children, allergic reactions, and stomach bleeding—but hair loss is notably absent from the documented side effects.

Indirect Effect on Hair Loss Treatment

While aspirin doesn't cause hair loss directly, there is one clinically relevant interaction:

  • Aspirin reduces minoxidil efficacy: Low-dose daily aspirin (75-81 mg) significantly inhibits sulfotransferase enzyme activity in hair follicles, which is required to convert minoxidil into its active form 2
  • In a 2018 study, after 14 days of aspirin use, the proportion of predicted minoxidil responders dropped from 50% to 27% 2
  • This matters specifically for women using topical minoxidil for androgenetic alopecia (pattern hair loss)

Evidence from Drug-Induced Alopecia Literature

When examining comprehensive reviews of drug-induced alopecia:

  • A 1995 review mentions that "hair loss from salicylates or nonsteroidal analgesics occurs in a very small percentage of patients" 3
  • However, a 1994 systematic review of drug-induced hair loss lists anticoagulants as potential causes of telogen effluvium but does not specifically highlight aspirin as a common culprit 4
  • A 2025 analysis of the FDA's Adverse Events Reporting System database examining 39,346 hair loss reports found that immunomodulatory agents, monoclonal antibodies, and contraceptives were most commonly associated with alopecia—aspirin was not among the frequently reported medications 5
  • A 2023 review of commonly prescribed medications with high-level evidence for alopecia associations did not include aspirin among the 13 drugs with strong evidence 6

Clinical Interpretation

The evidence hierarchy here is clear:

  1. FDA labeling (highest priority): No documented association
  2. Large-scale adverse event databases: No significant signal
  3. Systematic reviews: Only rare, isolated case reports with salicylates
  4. Mechanistic concern: Interference with minoxidil metabolism, not direct hair loss

Clinical Recommendations

For women concerned about hair loss while taking aspirin:

  • Aspirin itself should not be discontinued due to alopecia concerns, as it does not cause hair loss
  • If a woman is taking both aspirin and topical minoxidil for hair loss, counsel her that the aspirin may reduce minoxidil's effectiveness
  • Consider alternative cardiovascular prophylaxis if minoxidil treatment is critical and failing, though this decision requires careful risk-benefit analysis with cardiology input
  • If new hair loss develops in a woman taking aspirin, investigate other causes (thyroid disease, iron deficiency, autoimmune conditions, other medications) rather than attributing it to aspirin

Important Caveat

The distinction between "causing alopecia" and "reducing hair regrowth treatment efficacy" is clinically meaningful. Aspirin falls into the latter category only when combined with minoxidil therapy 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.